An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)
NCT06556056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108
Last updated 2025-09-09
Summary
This is an exploratory, prospective, three-arm, interventional, comparative, randomized, double-blind, placebo-controlled, safety, efficacy and in-use tolerability study of hair growth products in the patients mild to moderate androgenic alopecia (Grade I to III).
Conditions
- Androgenic Alopecia
Interventions
- OTHER
-
SesZen-Bio Serum
Mode of Usage: Dispense a small amount of serum directly onto your fingertips and gently massage it into the roots and scalp using circular motions to ensure even distribution and absorption. Continue this process across your entire scalp, focusing on areas that need the most attention. Avoid rinsing the serum out; instead, allow it to absorb fully. Dosage form: Liduid Frequency: Daily Night application. Route of administration: Topical
- OTHER
-
Minoxidil hair serum (1%)
Mode of Usage: Dispense a small amount of serum directly onto your fingertips and gently massage it into the roots and scalp using circular motions to ensure even distribution and absorption. Continue this process across your entire scalp, focusing on areas that need the most attention. Avoid rinsing the serum out; instead, allow it to absorb fully. Dosage form: Liquid Frequency: Daily Night Application Route of administration: Topical
- OTHER
-
Placebo
Mode of Usage: Dispense a small amount of serum directly onto your fingertips and gently massage it into the roots and scalp using circular motions to ensure even distribution and absorption. Continue this process across your entire scalp, focusing on areas that need the most attention. Avoid rinsing the serum out; instead, allow it to absorb fully. Dosage form: Liquid Frequency: Daily Night Application Route of administration: Topical
- OTHER
-
Liposomal Form of SesZenBio
Mode of Usage: Dispense a small amount of serum directly onto your fingertips and gently massage it into the roots and scalp using circular motions to ensure even distribution and absorption. Continue this process across your entire scalp, focusing on areas that need the most attention. Avoid rinsing the serum out; instead, allow it to absorb fully. Frequency: Daily Night Application Rout of administration: Topical
- OTHER
-
Minoxidil Hair Serum (5%)
Mode of Usage: Dispense a small amount of serum directly onto your fingertips and gently massage it into the roots and scalp using circular motions to ensure even distribution and absorption. Continue this process across your entire scalp, focusing on areas that need the most attention. Avoid rinsing the serum out; instead, allow it to absorb fully. Frequency: Daily Night Application Rout of administration: Topical
- OTHER
-
SesZen-Bio Serum + SesZen-Bio 350 mg extract
Mode of Usage of serum: Dispense a small amount of serum directly onto your fingertips and gently massage it into the roots and scalp using circular motions to ensure even distribution and absorption. Continue this process across your entire scalp, focusing on areas that need the most attention. Avoid rinsing the serum out; instead, allow it to absorb fully. Frequency: Daily Night Application Rout of administration: Topical Mode of Usage of Capsule: Swallow the capsule whole with a full glass of water without chewing, crushing, or opening it. Frequency: One time daily after meal Rout of administration: Oral
Sponsors & Collaborators
-
Zywie Ventures Privated Ltd
collaborator UNKNOWN -
NovoBliss Research Pvt Ltd
lead OTHER
Principal Investigators
-
Dr. Nayan K Patel · NovoBliss Research Pvt Ltd
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-06-30
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- India
Study Locations
More Related Trials
-
A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males
NCT02067260 ·Status: COMPLETED ·Phase: NA
-
Proof-of-Science, Prospective, Interventional, Three-arm, Double-Blind, Randomized, Safety and Efficacy Real World Evidence Study.
NCT06552039 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Hair Regeneration in Androgenetic Alopecia
NCT06066827 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
NCT01309191 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
NCT01325337 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients
NCT01655108 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes
NCT07203599 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
NCT00958750 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial in Females With Female Pattern Hair Loss
NCT01145625 ·Status: COMPLETED ·Phase: PHASE3
-
Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia
NCT02460289 ·Status: COMPLETED ·Phase: NA
-
Autologous Stromal Vascular Fraction in Treatment of Male Androgenic Alopecia
NCT06326359 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
NCT02676310 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men
NCT05636904 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
NCT07107841 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia
NCT01501617 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
NCT07273799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
NCT03535233 ·Status: COMPLETED ·Phase: PHASE4
-
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
NCT05417308 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
NCT05910450 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.
NCT06764329 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
NCT07076706 ·Status: COMPLETED ·Phase: PHASE2
-
Various Procedural Treatment Options for Androgenetic Alopecia
NCT06826001 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)
NCT01451125 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia
NCT01286649 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients
NCT06562894 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2